The Midlands Partnership Foundation Trust has begun a review of the treatment of 1,400 patients with autism who received treatment under its children and young people’s mental health service amid concerns that some had received “inappropriate” treatment.
The Trust, who provide mental health services to children and young people in Shropshire, took over the provision of service in May 2017, have begun reviewing cases of children with autism and ADHD who were treated by the previous provider, Shropshire Community Health Trust, with a “medication only” approach.
Prompted by an NHS England campaign to stop the over medication of people with learning disabilities and autism (STOMP), HSJ reported that the Trust have now started reviewing the care of 1,400 patients in order to establish the proportion of those who were exclusively treated with medication.
Board papers seen by HSJ by the Shropshire Clinical Commissioning Group said: “The background to [the intensive support team’s] visit was that both CCGs [Shropshire and Telford and Wrekin] had missed the 30 per cent access target for 17/18, there had been concerns about waiting times and inappropriate treatment since taking over from the previous provider and, a significant number of ‘legacy’ children and young people being treated for a conduct disorder or ASD/ADHD being treated with medication only approaches.”
NHS England’s STOMP campaign has been rolled out amid concerns that up to 35,000 adults with learning disabilities in England are taking psychotropic medications which have not been correctly prescribed for their health conditions – a problem also affecting children and young people.
This can cause them to put on weight, feel tired or “drugged up,” and more seriously, cause serious complications and problems with their physical health.Get your copy of UNITE Magazine